Active Start-up Investment Opportunities

Innovations created at UHN have resulted in a number of successful start-ups.  TDC constantly seeks investors for its new technology companies—ranging from earlier-stage companies seeking to launch, to well-established start-ups.  Current start-up investment opportunities include:

• IDO  Inhibitors 

• Porphysome

• brAIn

• Dnamx

• Repulsive Guidance Molecules

• SaluTech

Contact information for each of these investment opportunities is provided in the opportunity summaries above.

Technology Licensing to Spin-out Companies

TDC also licenses technology to spin-out companies.  Please contact TDC to arrange a conversation with one of our Licensing and Commercialization Professionals regarding your interests in licensing UHN technology to a spin-out company.